Scientific Papers 12 April 2020 SARS-CoV-2 on surfaces & air in hospital wards A dispatch paper in Emerging Infectious Diseases (of CDC) has reported on, ' Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in
Therapeutics 11 April 2020 Convalescent plasma for COVID-19 treatment - Why and How A peer reviewed article [https://onlinelibrary.wiley.com/doi/abs/10.1111/vox.12926] discusses the use of convalescent plasma, i.e. passive polyclonal antibody
Scientific Papers 9 April 2020 Loss of Smell and Taste is a strong indicator or COVID-19 infection Two papers (one non-peer reviewed, preprint) have reported that loss of smell (olfactory) and taste are a significant indication of COVID-19 infection. A peer reviewed
Scientific Papers 7 April 2020 Possible Faecal-Oral transmission of SARS-CoV-2 A study from China attests to the Prolonged presence of SARS-CoV-2 viral RNA in faecal samples [https://www.thelancet.com/journals/langas/article/PIIS2468-1253(20)
Scientific Papers 7 April 2020 Cloth Masks need to be used with Caution - 2015 Study 'A cluster randomised trial of cloth masks compared with medical masks in healthcare workers [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420971/]'
Scientific Papers 7 April 2020 EIDD-2801, a NHC prodrug inhibits SARS-CoV-2 in cell cultures and mice A paper published in Science Translational Medicine, reports that, 'prophylactic and therapeutic administration of EIDD-2801, an orally bioavailable NHC-prodrug (β-D-N4-hydroxycytidine-5′-isopropyl ester) - a
Scientific Papers 7 April 2020 Higher climate temperature associated with lower COVID-19 incidence A non-peer reviewed pre-print paper attempts to provide data to support the ongoing theory that increased temperature reduced transmission of SARS-CoV-2, although there has been
Scientific Papers 6 April 2020 SARS-CoV-2 replicates in the throat, shedding beyond symptomatic period Pharyngeal virus shedding was very high during the first week of symptoms. Infectious virus was readily isolated from throat- and lung-derived samples, but not from
Therapeutics 6 April 2020 Therapeutic plasma exchange for fulminant COVID-19 - Advocacy article Chinese authorities have reported success treating infected patients with donated plasma from survivors of the illness, the proposed benefit being protective antibodies formed by the
Therapeutics 6 April 2020 Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy Abstract Background A relatively high mortality of severe coronavirus disease 2019 (COVID‐19) is worrying, the application of heparin in COVID‐19 has been recommended
Scientific Papers 6 April 2020 Stability of SARS-CoV-2 in different environmental conditions The stability of SARS-CoV-2 in different environmental conditions. Notably, casual contact with a surface such as printed or tissue papers does not have the potential
Scientific Papers 6 April 2020 Airborne Transmission of COVID-19 - evidence Much remains unknown about COVID-19 transmission. Researchers have evaluated potential transmission routes from two community COVID-19 outbreaks and have concluded that Airborne spread of COVID-19
Scientific Papers 4 April 2020 Ivermectin is a potent inhibitor of SARS-CoV-2 Ivermectin is an inhibitor of SARS-CoV-2
Scientific Papers 30 March 2020 SARS-CoV-2 integrity on contaminated surfaces stays intact for hours and even days: Study. A letter to the editor titled, 'Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 [https://www.nejm.org/doi/10.1056/NEJMc2004973]
Scientific Papers 29 March 2020 49 Days Lockdown maybe required for India - forecast From the Paper: A three-week lockdown is found insufficient to prevent a resurgence and, instead, protocols of sustained lockdown with periodic relaxation are suggested. Forecasts are provided for the reduction in age-structured morbidity and mortality as a result of these measures.